AMCR vs ZNTL · P/E 18, rev $23.51B vs $257.7M cap
Amcor PLC (AMCR) versus Zentalis Pharmaceuticals Llc (ZNTL) — a side-by-side from cached financials, not a winner call.
Amcor PLC (AMCR) is a packaging & containers company listed on US.
Zentalis Pharmaceuticals Llc (ZNTL) is a biotechnology company listed on NASDAQ.
Latest reported AMCR revenue for 2026-06-30 was $23.51B. Net income was $1.11B. AMCR currently screens at market cap $22.52B and trailing P/E 17.6.
Latest reported ZNTL revenue for 2025-09-30 was $0. Net income was -$26.7M. ZNTL currently screens at market cap $257.7M.
AMCR currently screens at market cap $22.52B and trailing P/E 17.6. ZNTL currently screens at market cap $257.7M.
Not investment advice. Open the AMCR and ZNTL stock pages for the full models.
Not investment advice.